Relapse Recurrence

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-27
Clinical Trial Update: A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma [Phase 2]
A Phase 2 trial evaluating PD-1 inhibitor combined with ICE chemotherapy for relapsed/refractory Gray Zone Lymphoma.